TitreAuteur(s)RevueAnnéeVol­umePagePMID
[12-year his­to­ry of rad­i­cal surgery indi­ca­tions for the treat­ment of prostate can­cer].Rose Dite Mod­es­tine, J ; Neuzil­let, Y ; Herve, JM ; Bos­set, PO ; Abdou, A ; Bohin, D & alProg Urol201931280925
Epi­tope load iden­ti­fies kid­ney trans­plant recip­i­ents at risk of allosen­si­ti­za­tion fol­low­ing min­i­miza­tion of immuno­sup­pres­sion.Snanoudj, R ; Kamar, N ; Cas­su­to, E ; Cail­lard, S ; Met­zger, M ; Merville, P & alKid­ney Int2019951471–148530955869
Arche­type Analy­sis Iden­ti­fies Dis­tinct Pro­files in Renal Trans­plant Recip­i­ents with Trans­plant Glomeru­lopa­thy Asso­ci­at­ed with Allo­graft Sur­vival.Aubert, O ; Hig­gins, S ; Boua­tou, Y ; Yoo, D ; Ray­naud, M ; Vigli­et­ti, D & alJ Am Soc Nephrol201930625–63930872323
Mul­ti­ple recur­rences and risk of dis­ease pro­gres­sion in patients with pri­ma­ry low-grade (TaG1) non-mus­cle-inva­sive blad­der can­cer and with low and inter­me­di­ate EORTC-risk score.Simon, M ; Bos­set, PO ; Rouanne, M ; Ben­hamou, S ; Rad­ules­cu, C ; Molin­ié, V & alPLoS One201914e021172130811419
Con­ver­sion from cal­cineurin inhibitors to belat­a­cept in HLA- sen­si­tized kid­ney-trans­plant recip­i­ents with low-lev­el donor spe­cif­ic anti­bod­ies.Ulloa, CE ; Anglicheau, D ; Snanoudj, R ; Scem­la, A ; Mar­tinez, F ; Tim­sit, MO & alTrans­plan­ta­tion201930720681
Low inci­dence of acute rejec­tion with­in 6 months of kid­ney trans­plan­ta­tion in HIV-infect­ed recip­i­ents treat­ed with ral­te­gravir: the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) 153 TREVE tri­al.Matignon, M ; Lelièvre, JD ; Lahi­ani, A ; Abbassi, K ; Desvaux, D ; Dial­lo, A & alHIV Med201920202–21330688008
F‑FDG PET/CT improves pre­op­er­a­tive lymph node stag­ing for patients with inva­sive blad­der can­cer.Girard, A ; Rouanne, M ; Taconet, S ; Rad­ules­cu, C ; Neuzil­let, Y ; Gir­ma, A & alEur Radi­ol2019294286–429330666449
Stro­mal lym­pho­cyte infil­tra­tion is asso­ci­at­ed with tumour inva­sion depth but is not prog­nos­tic in high-grade T1 blad­der can­cer.Rouanne, M ; Betari, R ; Rad­ules­cu, C ; Goubar, A ; Sig­nolle, N ; Neuzil­let, Y & alEur J Can­cer2019108111–11930654296
Recur­rent acti­vat­ing muta­tions of PPARγ asso­ci­at­ed with lumi­nal blad­der tumors.Rochel, N ; Kruck­er, C ; Coutos-Thévenot, L ; Osz, J ; Zhang, R ; Guy­on, E & alNat Com­mun20191025330651555
[Short ver­sion of rec­om­men­da­tions for enhanced recov­ery pro­gram (ERP) for cys­tec­to­my: Tech­ni­cal mea­sures].Poinas, G ; Blache, JL ; Kassab-Chah­mi, D ; Evrard, PL ; Artus, PM ; Alfon­si, P & alProg Urol20192963–7530635149
Base­line graft sta­tus is a crit­i­cal pre­dic­tor of kid­ney graft fail­ure after diar­rhoea.Devresse, A ; Morin, L ; Aulagnon, F ; Taupin, JL ; Scem­la, A ; Lanternier, F & alNephrol Dial Trans­plant201930608553
Char­ac­ter­i­za­tion of Tes­tic­u­lar Mass­es in Adults: Per­for­mance of Com­bined Quan­ti­ta­tive Shear Wave Elas­tog­ra­phy and Con­ven­tion­al Ultra­sound.Rocher, L ; Criton, A ; Gen­nis­son, JL ; Creze, M ; Albiges, L ; Fer­li­cot, S & alUltra­sound Med Biol201945720–73130600129
PARP inhi­bi­tion enhances tumor cell-intrin­sic immu­ni­ty in ERC­C1-defi­cient non-small cell lung can­cer.Cha­banon, RM ; Muir­head, G ; Krastev, DB ; Adam, J ; Morel, D ; Gar­ri­do, M & alJ Clin Invest20191291211–122830589644
Cri­te­ria for indi­ca­tion and treat­ment mod­i­fi­ca­tion in a cohort of patients with prostate can­cer treat­ed with hor­mone ther­a­py.Lebret, T ; Ruf­fion, A ; Latorz­eff, I ; Zer­bib, M ; More­au, JL ; Rossi, D & alTher Adv Urol201810365–37630574196
No clin­i­cal ben­e­fit of rapid ver­sus grad­ual taper­ing of immuno­sup­pres­sion to treat sus­tained BK virus viremia after kid­ney trans­plan­ta­tion: a sin­gle-cen­ter expe­ri­ence.Devresse, A ; Tinel, C ; Ver­morel, A ; Snanoudj, R ; Morin, L ; Avet­tand-Fenoel, V & alTranspl Int201932481–49230565748
AVIATOR: An open inter­na­tion­al reg­istry to eval­u­ate med­ical and sur­gi­cal out­comes of aor­tic valve insuf­fi­cien­cy and ascend­ing aor­ta aneurysm.de Heer, F ; Kluin, J ; Elkhoury, G ; Jon­deau, G ; Enriquez-Sara­no, M ; Schäfers, HJ & alJ Tho­rac Car­dio­vasc Surg20191572202–2211.e730553597
Ultra­sen­si­tive Doppler as a tool for the diag­no­sis of tes­tic­u­lar ischemia dur­ing the Val­sal­va maneu­ver: a new way to explore varic­o­ce­les?Rocher, L ; Gen­nis­son, JL ; Barranger, J ; Rachas, A ; Criton, A ; Izard, V & alActa Radi­ol201828418511881098030396287
[French ccA­FU guide­lines — Update 2018–2020: Prostate can­cer].Rozet, F ; Hen­nequin, C ; Beau­val, JB ; Beuze­boc, P ; Cormi­er, L ; Fromont-Han­kard, G & alProg Urol201828S79-S13030392712
An open-label ran­dom­ized con­trolled tri­al of low-dose cor­ti­cos­teroid plus enteric-coat­ed mycophe­no­late sodi­um ver­sus stan­dard cor­ti­cos­teroid treat­ment for min­i­mal change nephrot­ic syn­drome in adults (MSN Study).Rémy, P ; Audard, V ; Natel­la, PA ; Pelle, G ; Dus­sol, B ; Ler­ay-Mor­agues, H & alKid­ney Int2018941217–122630385039
Sex steroids in serum and pro­sta­t­ic tis­sue of human can­cer­ous prostate (STERKPROSER tri­al).Meu­nier, ME ; Neuzil­let, Y ; Ray­naud, JP ; Rad­ules­cu, C ; Ghoneim, T ; Fiet, J & alProstate201979272–28030370569
[French ccA­FU guide­lines — Update 2018–2020: Blad­der can­cer].Rouprêt, M ; Neuzil­let, Y ; Pig­not, G ; Com­pérat, E ; Audenet, F ; Houédé, N & alProg Urol201828S46-S7830366708
Iden­ti­fi­ca­tion of genet­ic caus­es for spo­radic steroid-resis­tant nephrot­ic syn­drome in adults.Gri­bou­val, O ; Boy­er, O ; Hum­mel, A ; Dan­tal, J ; Mar­tinez, F ; Sber­ro-Sous­san, R & alKid­ney Int2018941013–102230348286
[French ccA­FU guide­lines — Update 2018–2020: Upper tract urothe­lial car­ci­no­ma].Rouprêt, M ; Xyli­nas, E ; Col­in, P ; Houédé, N ; Com­pérat, E ; Audenet, F & alProg Urol201828S32-S4530318333
Aggres­sive­ness of Local­ized Prostate Can­cer: the Key Val­ue of Testos­terone Defi­cien­cy Eval­u­at­ed by Both Total and Bioavail­able Testos­terone: Andro­Can Study Results.Neuzil­let, Y ; Ray­naud, JP ; Drey­fus, JF ; Rad­ules­cu, C ; Rouanne, M ; Schnei­der, M & alHorm Can­cer20191036–4430293206
Mol­e­c­u­lar Sub­types of Urothe­lial Blad­der Can­cer: Results from a Meta-cohort Analy­sis of 2411 Tumors.Tan, TZ ; Rouanne, M ; Tan, KT ; Huang, RY ; Thiery, JPEur Urol201975423–43230213523
[ypT0N0 after neoad­ju­vant chemother­a­py and cys­tec­to­my for mus­cle-inva­sive blad­der can­cer: Inci­dence and prog­no­sis. A review from the Blad­der group of the French Com­mit­tee of Oncol­o­gy].Pig­not, G ; Houédé, N ; Roumigu­ié, M ; Audenet, F ; Brunelle, S ; Col­in, P & alProg Urol201828567–57430205925
Ben­e­fits of kid­ney trans­plan­ta­tion for a nation­al cohort of patients aged 70 years and old­er start­ing renal replace­ment ther­a­py.Leg­eai, C ; Andri­ana­so­lo, RM ; Moranne, O ; Snanoudj, R ; Hour­mant, M ; Bauwens, M & alAm J Trans­plant2018182695–270730203618
Tes­tic­u­lar tumours dis­cov­ered dur­ing infer­til­i­ty workup are pre­dom­i­nant­ly benign and could ini­tial­ly be man­aged by spar­ing surgery.Lagabrielle, S ; Durand, X ; Droupy, S ; Izard, V ; Mar­cel­li, F ; Huyghe, E & alJ Surg Oncol2018118630–63530196556
Preva­lence of athero­ma­tous and non-athero­ma­tous car­dio­vas­cu­lar dis­ease by age in chron­ic kid­ney dis­ease.Vil­lain, C ; Met­zger, M ; Combe, C ; Fouque, D ; Frimat, L ; Jacque­linet, C & alNephrol Dial Trans­plant201830169874
Risk fac­tors and man­age­ment of per­sis­tent post­par­tum uri­nary reten­tion.Tiberon, A ; Car­bon­nel, M ; Vidart, A ; Ben Hal­i­ma, M ; Deffieux, X ; Ayoubi, JMJ Gynecol Obstet Hum Reprod201847437–44130142472
Eval­u­a­tion of the ade­qua­cy of drug pre­scrip­tions in patients with chron­ic kid­ney dis­ease: results from the CKD-REIN cohort.Lav­ille, SM ; Met­zger, M ; Sten­gel, B ; Jacque­linet, C ; Combe, C ; Fouque, D & alBr J Clin Phar­ma­col2018842811–282330110711
[Does the delay from prostate biop­sy to rad­i­cal prosta­te­c­to­my influ­ence the risk of bio­chem­i­cal recur­rence?]Meu­nier, ME ; Neuzil­let, Y ; Rad­ules­cu, C ; Cher­bon­nier, C ; Hervé, JM ; Rouanne, M & alProg Urol201828475–48129907495
Rel­e­vance of uri­nary spe­cif­ic pro­tein assay in the diag­no­sis of kid­ney dis­eases.Fla­hault, A ; Chas­sé, JF ; Thervet, E ; Kar­ras, A ; Pal­let, NAnn Biol Clin (Paris)201876259–26929862969
Suni­tinib Alone or after Nephrec­to­my in Metasta­t­ic Renal-Cell Car­ci­no­ma.Méjean, A ; Ravaud, A ; Thezenas, S ; Colas, S ; Beau­val, JB ; Ben­salah, K & alN Engl J Med2018379417–42729860937
Devel­op­ment of immunother­a­py in blad­der can­cer: present and future on tar­get­ing PD(L)1 and CTLA‑4 path­ways.Rouanne, M ; Roumigu­ié, M ; Houédé, N ; Mas­son-Lecomte, A ; Col­in, P ; Pig­not, G & alWorld J Urol2018361727–174029855698
Post­op­er­a­tive Peri­toni­tis After Diges­tive Tract Surgery: Sur­gi­cal Man­age­ment and Risk Fac­tors for Mor­bid­i­ty and Mor­tal­i­ty, a Cohort of 191 Patients.Ben­sign­or, T ; Lefevre, JH ; Creav­in, B ; Chafai, N ; Lescot, T ; Hor, T & alWorld J Surg2018423589–359829850950
From arte­r­i­al stiff­ness to kid­ney graft microvas­cu­la­ture: Mor­tal­i­ty and graft sur­vival with­in a cohort of 220 kid­ney trans­plant recip­i­ents.Ched­dani, L ; Rad­ules­cu, C ; Chaignon, M ; Kar­ras, A ; Neuzil­let, Y ; Duong, JP & alPLoS One201813e019592829723212
Diag­no­sis and man­age­ment of asymp­to­matic bac­teri­uria in kid­ney trans­plant recip­i­ents: a sur­vey of cur­rent prac­tice in Europe.Cousse­ment, J ; Mag­giore, U ; Manuel, O ; Scem­la, A ; López-Medra­no, F ; Nagler, EV & alNephrol Dial Trans­plant2018331661–166829635410
[Pul­monary ultra­sound and dial­y­sis].Sei­d­owsky, A ; Vilaine, È ; Mansen­cal, N ; Ébel, A ; Vil­lain, C ; Ched­dani, L & alNephrol Ther201814 Sup­pl 1S73-S8129606266
Duo­de­nal repair with a jeju­nal pedi­cle graft.Ben­sign­or, T ; Rault, A ; Dubrez, JJ Visc Surg2018155141–14529598849
Pat­terns of Clin­i­cal Response to Eculizum­ab in Patients With C3 Glomeru­lopa­thy.Le Quin­trec, M ; Lapeyraque, AL ; Lionet, A ; Sel­l­i­er-Leclerc, AL ; Del­mas, Y ; Bau­douin, V & alAm J Kid­ney Dis20187284–9229429752
Acute hepati­tis A break­through in MSM in Paris area: imple­men­ta­tion of tar­get­ed hepati­tis A virus vac­cine in a con­text of vac­cine short­age.Far­four, E ; Lesprit, P ; Chan Hew Wai, A ; Maza­ux, L ; Fourn, E ; Majer­holc, C & alAIDS201832531–53229381561
Blood Gene Expres­sion Pre­dicts Bron­chi­oli­tis Oblit­er­ans Syn­drome.Dan­ger, R ; Roy­er, PJ ; Reboul­leau, D ; Durand, E ; Loy, J ; Tis­sot, A & alFront Immunol20178184129375549
Decreased darunavir con­cen­tra­tions dur­ing once-dai­ly co-admin­is­tra­tion with mar­avi­roc and ral­te­gravir: OPTIPRIM-ANRS 147 tri­al.Pres­si­at, C ; Hirt, D ; Tre­luy­er, JM ; Zheng, Y ; Mor­lat, P ; Naqvi, A & alJ Antimi­crob Chemoth­er2018731020–102429365125
Dynam­ic Prog­nos­tic Score to Pre­dict Kid­ney Allo­graft Sur­vival in Patients with Anti­body-Medi­at­ed Rejec­tion.Vigli­et­ti, D ; Loupy, A ; Aubert, O ; Bestard, O ; Duong Van Huyen, JP ; Taupin, JL & alJ Am Soc Nephrol201829606–61929255058
Iso­lat­ed v‑lesion in kid­ney trans­plant recip­i­ents: Char­ac­ter­is­tics, asso­ci­a­tion with DSA, and his­to­log­i­cal fol­low-up.Rabant, M ; Boul­lenger, F ; Gnem­mi, V ; Pel­lé, G ; Glowac­ki, F ; Her­tig, A & alAm J Trans­plant201818972–98129206350
[Epi­demi­ol­o­gy of urolithi­a­sis in French West Indies: A ret­ro­spec­tive study].Kaulan­jan, K ; Cer­ru­ti, A ; Galan­tine, V ; Laine, C ; Rose Dite Mod­es­tine, J ; Gour­taud, G & alProg Urol201828114–11929162379
Val­ue of bio­mark­ers for pre­dict­ing immunoglob­u­lin A vas­culi­tis nephri­tis out­come in an adult prospec­tive cohort.Berth­elot, L ; Jamin, A ; Vigli­et­ti, D ; Chemouny, JM ; Ayari, H ; Pierre, M & alNephrol Dial Trans­plant2018331579–159029126311
Qual­i­ta­tive and quan­ti­ta­tive con­trast-enhanced ultra­sonog­ra­phy for the char­ac­ter­i­sa­tion of non-pal­pa­ble tes­tic­u­lar tumours.Luzuri­er, A ; Maxwell, F ; Cor­reas, JM ; Benoit, G ; Izard, V ; Fer­li­cot, S & alClin Radi­ol201873322.e1-322.e929122221
Screen­ing for intracra­nial aneurysms in auto­so­mal dom­i­nant poly­cys­tic kid­ney dis­ease is cost-effec­tive.Fla­hault, A ; Trys­tram, D ; Nataf, F ; Fouchard, M ; Knebel­mann, B ; Grün­feld, JP & alKid­ney Int201893716–72629061331
Man­age­ment of renal trans­plant urolithi­a­sis: a mul­ti­cen­tre study by the French Urol­o­gy Asso­ci­a­tion Trans­plan­ta­tion Com­mit­tee.Branchere­au, J ; Tim­sit, MO ; Neuzil­let, Y ; Bessède, T ; Thuret, R ; Gigante, M & alWorld J Urol201836105–10929058024
Cen­tral anti­hy­per­ten­sive effects of chron­ic treat­ment with RB150: an oral­ly active aminopep­ti­dase A inhibitor in deoxy­cor­ti­cos­terone acetate-salt rats.Marc, Y ; Hmaz­zou, R ; Bal­avoine, F ; Fla­hault, A ; Llorens-Cortes, CJ Hyper­tens201836641–65028968260
Long-Term Func­tion­al Out­comes of S3 Sacral Neu­ro­mod­u­la­tion for the Treat­ment of Idio­path­ic Over­ac­tive Blad­der.Ismail, S ; Charti­er-Kastler, E ; Per­rouin-Verbe, MA ; Rose-Dite-Mod­es­tine, J ; Denys, P ; Phé, VNeu­ro­mod­u­la­tion201720825–82928967986
Increase in sex­u­al­ly trans­mit­ted infec­tions in a cohort of out­pa­tient HIV-pos­i­tive men who have sex with men in the Parisian region.Far­four, E ; Dimi, S ; Majer­holc, C ; Fourn, E ; Séné, T ; Chai­da, MB & alMed Mal Infect201747490–49328943174
Sex­u­al steroids in serum and pro­sta­t­ic tis­sue of human non-can­cer­ous prostate (STERPROSER tri­al).Neuzil­let, Y ; Ray­naud, JP ; Rad­ules­cu, C ; Fiet, J ; Giton, F ; Drey­fus, JF & alProstate2017771512–151928905453
Rever­sal of Arte­r­i­al Stiff­ness and Mal­adap­ta­tive Arte­r­i­al Remod­el­ing After Kid­ney Trans­plan­ta­tion.Kar­ras, A ; Boutouyrie, P ; Bri­et, M ; Bozec, E ; Hay­mann, JP ; Legendre, C & alJ Am Heart Assoc2017628889098
IGF1R acti­va­tion and the in vit­ro antipro­lif­er­a­tive effi­ca­cy of IGF1R inhibitor are inverse­ly cor­re­lat­ed with IGFBP5 expres­sion in blad­der can­cer.Neuzil­let, Y ; Cha­peaublanc, E ; Kruck­er, C ; De Kon­ing, L ; Lebret, T ; Rad­vanyi, F & alBMC Can­cer20171763628882129
Cytomegalovirus infec­tion man­age­ment in sol­id organ trans­plant recip­i­ents across Euro­pean cen­ters in the time of mol­e­c­u­lar diag­nos­tics: An ESGICH sur­vey.Navar­ro, D ; San-Juan, R ; Manuel, O ; Giménez, E ; Fer­nán­dez-Ruiz, M ; Hirsch, HH & alTranspl Infect Dis20171928859257
Liraglu­tide and Renal Out­comes in Type 2 Dia­betes.Mann, JFE ; Ørst­ed, DD ; Brown-Frand­sen, K ; Mar­so, SP ; Poul­ter, NR ; Ras­mussen, S & alN Engl J Med2017377839–84828854085
Lung can­cer in renal trans­plant recip­i­ents: A case-con­trol study.Rousseau-Gazan­iol, C ; Fraboulet, S ; Coud­erc, LJ ; Kreis, H ; Borie, R ; Tri­cot, L & alLung Can­cer201711196–10028838407
Long-term out­comes and risks fac­tors for fail­ure of intrade­tru­sor onabot­u­linum­tox­in A injec­tions for the treat­ment of refrac­to­ry neu­ro­genic detru­sor over­ac­tiv­i­ty.Jous­sain, C ; Popoff, M ; Phé, V ; Even, A ; Bos­set, PO ; Pot­ti­er, S & alNeu­rourol Uro­dyn201837799–80628745807
Air­way micro­bio­ta sig­nals ana­bol­ic and cata­bol­ic remod­el­ing in the trans­plant­ed lung.Mouraux, S ; Bernasconi, E ; Pat­ta­roni, C ; Kout­sok­era, A ; Aubert, JD ; Claus­tre, J & alJ Aller­gy Clin Immunol2018141718–729.e728729000
Exist­ing report­ing guide­lines for clin­i­cal tri­als are not com­plete­ly rel­e­vant for implantable med­ical devices: a sys­tem­at­ic review.Motte, AF ; Dial­lo, S ; van den Brink, H ; Château­vieux, C ; Ser­ra­no, C ; Naud, C & alJ Clin Epi­demi­ol201791111–12028728922
[Qual­i­ty of life of patients car­ry­ing an uri­nary diver­sion].Neuzil­let, Y ; Rouprêt, MProg Urol201727845–85028684066
Role of the Vasopressin/Apelin Bal­ance and Poten­tial Use of Meta­bol­i­cal­ly Sta­ble Apelin Analogs in Water Metab­o­lism Dis­or­ders.Fla­hault, A ; Cou­vineau, P ; Alvear-Perez, R ; Itur­rioz, X ; Llorens-Cortes, CFront Endocrinol (Lau­sanne)2017812028620355
[Screen­ing and man­age­ment of intracra­nial aneurisms in patients with auto­so­mal dom­i­nant poly­cys­tic kid­ney dis­ease].Fla­hault, A ; Knebel­mann, B ; Nataf, F ; Trys­tram, D ; Grün­feld, JP ; Joly, DNephrol Ther201713 Sup­pl 1S147-S15328577737
F‑fluorocholine is non-con­tribu­tive].Gau­thé, M ; Belis­sant, O ; Girard, A ; Zhang Yin, J ; Ohnona, J ; Cot­tereau, AS & alProg Urol201727474–48128576423
Tes­tic­u­lar ultra­sen­si­tive Doppler pre­lim­i­nary expe­ri­ence: a fea­si­bil­i­ty study.Rocher, L ; Gen­nis­son, JL ; Fer­li­cot, S ; Criton, A ; Albiges, L ; Izard, V & alActa Radi­ol201859346–35428569117
Clin­i­cal Prac­tice Guide­lines: Syn­the­sis of the guide­lines for the sur­gi­cal treat­ment of pri­ma­ry pelvic organ pro­lapse in women by the AFU, CNGOF, SIFUD-PP, SNFCP, and SCGP.Le Nor­mand, L ; Cos­son, M ; Cour, F ; Deffieux, X ; Donon, L ; Fer­ry, P & alJ Gynecol Obstet Hum Reprod201746387–39128506877
Onco­log­i­cal and func­tion­al out­comes of sex­u­al func­tion-pre­serv­ing cys­tec­to­my com­pared with stan­dard rad­i­cal cys­tec­to­my in men: A sys­tem­at­ic review.Hernán­dez, V ; Espinos, EL ; Dunn, J ; MacLen­nan, S ; Lam, T ; Yuan, Y & alUrol Oncol201735539.e17-539.e2928495555
Glea­son Score with­in Prostate Abnor­mal Areas Defined by Mul­ti­para­met­ric Mag­net­ic Res­o­nance Imag­ing Did Not Vary Accord­ing to the PIRADS Score.Slaoui, H ; Neuzil­let, Y ; Ghoneim, T ; Rouanne, M ; Abdou, A ; Lugagne-Delpon, PM & alUrol Int201799156–16128391284
Out­come and Treat­ment of Nocar­dio­sis After Sol­id Organ Trans­plan­ta­tion: New Insights From a Euro­pean Study.Lebeaux, D ; Fre­und, R ; van Delden, C ; Guil­lot, H ; Mar­bus, SD ; Matignon, M & alClin Infect Dis2017641396–140528329348
Prog­nos­tic val­ue of cere­bral tis­sue oxy­gen sat­u­ra­tion dur­ing neona­tal extra­cor­po­re­al mem­brane oxy­gena­tion.Clair, MP ; Ram­baud, J ; Fla­hault, A ; Guedj, R ; Guil­bert, J ; Guel­lec, I & alPLoS One201712e017299128278259
Sys­tem­at­ic review of the onco­log­i­cal and func­tion­al out­comes of pelvic organ-pre­serv­ing rad­i­cal cys­tec­to­my (RC) com­pared with stan­dard RC in women who under­go cura­tive surgery and ortho­topic neoblad­der sub­sti­tu­tion for blad­der can­cer.Veskimäe, E ; Neuzil­let, Y ; Rouanne, M ; MacLen­nan, S ; Lam, TBL ; Yuan, Y & alBJU Int201712012–2428220653
A prospec­tive obser­va­tion­al study on the eval­u­a­tion of everolimus-relat­ed adverse events in metasta­t­ic renal cell car­ci­no­ma after first-line anti-vas­cu­lar endothe­lial growth fac­tor ther­a­py: the AFINITE study in France.Joly, F ; Eymard, JC ; Albiges, L ; Nguyen, T ; Guil­lot, A ; Rol­land, F & alSup­port Care Can­cer2017252055–206228188447
Remod­el­ing root repair with an exter­nal aor­tic ring annu­lo­plas­ty.Lansac, E ; Di Cen­ta, I ; Sleilaty, G ; Leje­une, S ; Berre­bi, A ; Zacek, P & alJ Tho­rac Car­dio­vasc Surg20171531033–104228187973
The mea­sured glomeru­lar fil­tra­tion rate (mGFR) before and 6 months after bariatric surgery: A pilot study.Clerte, M ; Wag­n­er, S ; Carette, C ; Brodin-Sar­to­rius, A ; Vilaine, É ; Alvarez, JC & alNephrol Ther201713160–16728161263
Anti-Fac­tor B and Anti-C3b Autoan­ti­bod­ies in C3 Glomeru­lopa­thy and Ig-Asso­ci­at­ed Mem­bra­nopro­lif­er­a­tive GN.Mari­nozzi, MC ; Roumeni­na, LT ; Chau­vet, S ; Her­tig, A ; Bertrand, D ; Olagne, J & alJ Am Soc Nephrol2017281603–161328096309
[Renal abnor­mal­i­ties].Mes­si­ka, J ; Nah­mani, Y ; Aouad, P ; Berquier, G ; Roux, D ; Dela­housse, MRev Med Interne201839600–60128081902
Tes­tic­u­lar Shear Wave Elas­tog­ra­phy in Nor­mal and Infer­tile Men: A Prospec­tive Study on 601 Patients.Rocher, L ; Criton, A ; Gen­nis­son, JL ; Izard, V ; Fer­li­cot, S ; Tan­ter, M & alUltra­sound Med Biol201743782–78928062178
Induced pluripo­tent stem cell gen­er­a­tion from a man car­ry­ing a com­plex chro­mo­so­mal rearrange­ment as a genet­ic mod­el for infer­til­i­ty stud­ies.Mou­ka, A ; Izard, V ; Tachd­jian, G ; Bris­set, S ; Yates, F ; Mayeur, A & alSci Rep201773976028045072
T Cells Pro­mote Bronchial Epithe­lial Cell Secre­tion of Matrix Metalloproteinase‑9 via a C‑C Chemokine Recep­tor Type 2 Path­way: Impli­ca­tions for Chron­ic Lung Allo­graft Dys­func­tion.Pain, M ; Roy­er, PJ ; Loy, J ; Girardeau, A ; Tis­sot, A ; Lacoste, P & alAm J Trans­plant2017171502–151427982503
Clin­i­cal impact of the CYP3A5 6986A>G allel­ic vari­ant on kid­ney trans­plan­ta­tion out­comes.Fla­hault, A ; Anglicheau, D ; Lori­ot, MA ; Thervet, E ; Pal­let, NPhar­ma­coge­nomics201718165–17327977332
Burned-Out Testis Tumors in Asymp­to­matic Infer­tile Men: Mul­ti­para­met­ric Sonog­ra­phy and MRI Find­ings.Rocher, L ; Glas, L ; Bellin, MF ; Fer­li­cot, S ; Izard, V ; Benoit, G & alJ Ultra­sound Med201736821–83127914180
Pre­op­er­a­tive Eval­u­a­tion of the Renal Func­tion before the Treat­ment of Abdom­i­nal Aor­tic Aneurysms.Coscas, R ; Wag­n­er, S ; Vilaine, E ; Sar­to­rius, A ; Javer­li­at, I ; Alvarez, JC & alAnn Vasc Surg201740162–16927890838
Tes­tic­u­lar Sper­ma­to­zoa Are of Bet­ter Qual­i­ty Than Epi­didy­mal Sper­ma­to­zoa in Patients With Obstruc­tive Azoosper­mia.Ham­moud, I ; Bail­ly, M ; Berg­ere, M ; Wain­er, R ; Izard, V ; Vialard, F & alUrol­o­gy2017103106–11127888149
[CCAFU french nation­al guide­lines 2016–2018 on prostate can­cer].Rozet, F ; Hen­nequin, C ; Beau­val, JB ; Beuze­boc, P ; Cormi­er, L ; Fromont, G & alProg Urol201627 Sup­pl 1S95-S14327846936
[CCAFU french nation­al guide­lines 2016–2018 on blad­der can­cer].Rouprêt, M ; Neuzil­let, Y ; Mas­son-Lecomte, A ; Col­in, P ; Com­pérat, E ; Dubosq, F & alProg Urol201627 Sup­pl 1S67-S9127846935
[CCAFU french nation­al guide­lines 2016–2018 on upper tract tumors].Rouprêt, M ; Col­in, P ; Xyli­nas, E ; Com­pérat, E ; Dubosq, F ; Houédé, N & alProg Urol201627 Sup­pl 1S55-S6627846934
Devel­op­ment of orig­i­nal meta­bol­i­cal­ly sta­ble apelin-17 analogs with diuret­ic and car­dio­vas­cu­lar effects.Ger­bier, R ; Alvear-Perez, R ; Mar­gathe, JF ; Fla­hault, A ; Cou­vineau, P ; Gao, J & alFASEB J201731687–70027815337
A prospec­tive mul­ti­cen­ter study on blad­der can­cer: the COBLAnCE cohort.Ben­hamou, S ; Bonas­tre, J ; Grous­sard, K ; Rad­vanyi, F ; Allo­ry, Y ; Lebret, TBMC Can­cer20161683727809812
[Clin­i­cal prac­tice guide­lines: Syn­the­sis of the guide­lines for the sur­gi­cal treat­ment of pri­ma­ry pelvic organ pro­lapse in women by the AFU, CNGOF, SIFUD-PP, SNFCP, and SCGP].Le Nor­mand, L ; Cos­son, M ; Cour, F ; Deffieux, X ; Donon, L ; Fer­ry, P & alJ Gynecol Obstet Biol Reprod (Paris)2016451606–161327776848
[Urog­y­ne­col­o­gy pelvic organ pro­lapse French sur­gi­cal train­ing dur­ing and after res­i­den­cy].Vigoureux, S ; Per­reaud, A ; Legendre, G ; Salet-Lizée, D ; Vil­let, RGynecol Obstet Fer­til201644664–66827751745
Case report and lit­er­a­ture review: Glomeru­lar and neu­ro­log­ic throm­bot­ic microan­giopa­thy as a pri­ma­ry man­i­fes­ta­tion of mul­ti­cen­tric castle­man dis­ease.Fla­hault, A ; Vignon, M ; Rabant, M ; Hum­mel, A ; Noël, LH ; Can­ioni, D & alMed­i­cine (Bal­ti­more)201695e504727741115
Adher­ence to and Accep­tance of Once-Dai­ly Tacrolimus After Kid­ney and Liv­er Trans­plant: Results From OSIRIS, a French Obser­va­tion­al Study.Cas­su­to, E ; Pageaux, GP ; Can­tarovich, D ; Ros­taing, L ; Loupy, A ; Roche, B & alTrans­plan­ta­tion20161002099–210627653227
[Andro­log­ic con­se­quences of chron­ic renal fail­ure: State of the art for the year­ly sci­en­tif­ic report of the French Nation­al Asso­ci­a­tion of Urol­o­gy].Neuzil­let, Y ; Thuret, R ; Klein­clauss, F ; Tim­sit, MOProg Urol2016261088–109327647650
[Are there selec­tion cri­te­ria between abdom­i­nal approach and vagi­nal route for gen­i­tal pro­lapse sur­gi­cal man­age­ment?].Cour, F ; Vidart, AProg Urol201626 Sup­pl 1S98-S10427595631
[Vagi­nal surgery and transanal approach for pos­te­ri­or vagi­nal wall pro­lapse: Guide­lines for clin­i­cal prac­tice].Cour, F ; Le Nor­mand, L ; Meurette, GProg Urol201626 Sup­pl 1S47-6027595626
[Is the use of syn­thet­ic mesh by vagi­nal route decrease the risk of cys­to­cele recur­rence? Clin­i­cal prac­tice guide­lines].Le Nor­mand, L ; Deffieux, X ; Donon, L ; Fat­ton, B ; Cour, FProg Urol201626 Sup­pl 1S38-4627595625
[Laparo­scop­ic sacro­colpopexy for pelvic organ pro­lapse: guide­lines for clin­i­cal prac­tice].Wag­n­er, L ; Meurette, G ; Vidart, A ; Warem­bourg, S ; Teras­sa, JB ; Berro­gain, N & alProg Urol201626 Sup­pl 1S27-3727595624
[Clin­i­cal prac­tice guide­lines: Sum­ma­ry of rec­om­men­da­tions for first sur­gi­cal treat­ment of female pelvic organ pro­lapse by 5 French aca­d­e­m­ic soci­eties: AFU, CNGOF, SIFUD-PP, SNFCP, and SCGP].Le Nor­mand, L ; Cos­son, M ; Cour, F ; Deffieux, X ; Donon, L ; Fer­ry, P & alProg Urol201626 Sup­pl 1S1‑727595623
Renal safe­ty of high-dose, sucrose-free intra­venous immunoglob­u­lin in kid­ney trans­plant recip­i­ents: an obser­va­tion­al study.Luque, Y ; Anglicheau, D ; Rabant, M ; El Karoui, K ; Jamme, M ; Aubert, O & alTranspl Int2016291205–121527529401
Mul­ti­pha­sic effects of blood pres­sure on sur­vival in hemodial­y­sis patients.Hannedouche, T ; Roth, H ; Krum­mel, T ; Lon­don, GM ; Jean, G ; Bouchet, JL & alKid­ney Int201690674–8427521114
Long-term results of exter­nal aor­tic ring annu­lo­plas­ty for aor­tic valve repair.Lansac, E ; Di Cen­ta, I ; Sleilaty, G ; Leje­une, S ; Khelil, N ; Berre­bi, A & alEur J Car­dio­tho­rac Surg201650350–6027440158
Osteo­pon­tin and thrombospondin‑1 play oppo­site roles in pro­mot­ing tumor aggres­sive­ness of pri­ma­ry resect­ed non-small cell lung can­cer.Rouanne, M ; Adam, J ; Goubar, A ; Robin, A ; Ohana, C ; Lou­vet, E & alBMC Can­cer20161648327422280
Updat­ed 2016 EAU Guide­lines on Mus­cle-inva­sive and Metasta­t­ic Blad­der Can­cer.Alfred Wit­jes, J ; Lebret, T ; Com­pérat, EM ; Cow­an, NC ; De San­tis, M ; Bru­ins, HM & alEur Urol201771462–47527375033
Rit­ux­imab for Severe Mem­bra­nous Nephropa­thy: A 6‑Month Tri­al with Extend­ed Fol­low-Up.Dahan, K ; Debiec, H ; Plaisi­er, E ; Cachana­do, M ; Rousseau, A ; Wak­sel­man, L & alJ Am Soc Nephrol201728348–35827352623
Iden­ti­fi­ca­tion of tar­get­ed ther­a­py for an aggres­sive sub­group of mus­cle-inva­sive blad­der can­cers.Lebret, T ; Neuzil­let, Y ; Houede, N ; Rebouis­sou, S ; Bernard-Pier­rot, I ; De Reynies, A & alMol Cell Oncol20152e99950727308521
Low Serum Cre­a­tine Kinase Lev­el Pre­dicts Mor­tal­i­ty in Patients with a Chron­ic Kid­ney Dis­ease.Fla­hault, A ; Met­zger, M ; Chas­sé, JF ; Hay­mann, JP ; Bof­fa, JJ ; Fla­mant, M & alPLoS One201611e015643327248151
[Com­bined heart and kid­ney trans­plan­ta­tion in Fabry”s dis­ease: Long-term out­comes in two patients].Tran Ba, SN ; Lidove, O ; Dorent, R ; Debauchez, M ; Nataf, P ; Dela­housse, M & alRev Med Interne201738137–14227241078
[Pre­dic­tive fac­tors and prog­nos­tic con­se­quences of peri­op­er­a­tive com­pli­ca­tions of rad­i­cal cys­tec­tomies for urothe­lial car­ci­no­ma in patients of 80 years or more].Chanu, T ; Neuzil­let, Y ; Butreau, M ; Bach, C ; Rouanne, M ; Lebret, TProg Urol201626331–827209221
Tumor het­ero­gene­ity of fibrob­last growth fac­tor recep­tor 3 (FGFR3) muta­tions in inva­sive blad­der can­cer: impli­ca­tions for peri­op­er­a­tive anti-FGFR3 treat­ment.Poues­sel, D ; Neuzil­let, Y ; Mertens, LS ; van der Hei­j­den, MS ; de Jong, J ; Sanders, J & alAnn Oncol2016271311–627091807
Nocar­dia Infec­tion in Sol­id Organ Trans­plant Recip­i­ents: A Mul­ti­cen­ter Euro­pean Case-con­trol Study.Cousse­ment, J ; Lebeaux, D ; van Delden, C ; Guil­lot, H ; Fre­und, R ; Mar­bus, S & alClin Infect Dis201663338–4527090987
The use of bis­pho­s­pho­nates in the man­age­ment of bone involve­ment from sol­id tumours and haema­to­log­i­cal malig­nan­cies — a Euro­pean sur­vey.Lebret, T ; Casas, A ; Cavo, M ; Woll, PJ ; Dele­place, C ; Kennedy, C & alEur J Can­cer Care (Engl)20172627072626
Screen­ing for Unrup­tured Intracra­nial Aneurysms in Auto­so­mal Dom­i­nant Poly­cys­tic Kid­ney Dis­ease: A Sur­vey of 420 Nephrol­o­gists.Fla­hault, A ; Trys­tram, D ; Fouchard, M ; Knebel­mann, B ; Nataf, F ; Joly, DPLoS One201611e015317627054719
A nation­al study of kid­ney graft tumor treat­ments: Toward abla­tive ther­a­py.Guleryuz, K ; Doer­fler, A ; Codas, R ; Cof­fin, G ; Hubert, J ; Lecheval­li­er, E & alSurgery2016160237–24427032620
Radiofre­quen­cy abla­tion and sur­gi­cal resec­tion of liv­er metas­tases from uveal melanoma.Mar­i­ani, P ; Almubarak, MM ; Kollen, M ; Wag­n­er, M ; Planch­er, C ; Audol­lent, R & alEur J Surg Oncol201642706–1226968227
[3D mod­el­ing of the female pelvis by Com­put­er-Assist­ed Anatom­i­cal Dis­sec­tion: Appli­ca­tions and per­spec­tives].Bal­aya, V ; Uhl, JF ; Lanore, A ; Salachas, C ; Samoyeau, T ; Ngo, C & alJ Gynecol Obstet Biol Reprod (Paris)201645467–7726897467
Ben­tall Pro­ce­dure: A Sys­tem­at­ic Review and Meta-Analy­sis.Mookhoek, A ; Kor­te­land, NM ; Arabkhani, B ; Di Cen­ta, I ; Lansac, E ; Bekkers, JA & alAnn Tho­rac Surg20161011684–926857635
[Obser­va­tion­al sur­vey of the French Uro­log­i­cal Asso­ci­a­tion Oncol­o­gy Com­mit­tee (CCAFU) eval­u­at­ing the prac­tice of imme­di­ate post­op­er­a­tive instil­la­tion (IPOP) using mit­o­mycin C for non-mus­cle inva­sive blad­der can­cer (NMIBC) treat­ment].Neuzil­let, Y ; Col­in, P ; Com­per­at, E ; Dubosq, F ; Houede, N ; Larre, S & alProg Urol201626181–9026777686
Dura­bil­i­ty and Effec­tive­ness of Mar­avi­roc-Con­tain­ing Reg­i­mens in HIV-1-Infect­ed Indi­vid­u­als with Viro­log­i­cal Fail­ure in Rou­tine Clin­i­cal Prac­tice.Potard, V ; Reynes, J ; Fer­ry, T ; Aubin, C ; Finkiel­sztejn, L ; Yaz­dan­panah, Y & alPLoS One201510e014474626714012
B7‑1 Block­ade Does Not Improve Post-Trans­plant Nephrot­ic Syn­drome Caused by Recur­rent FSGS.Delville, M ; Baye, E ; Dur­rbach, A ; Audard, V ; Kof­man, T ; Braun, L & alJ Am Soc Nephrol2016272520–726701979
[Assess­ment of the opti­miza­tion of the con­di­tions of mit­o­mycin C intrav­es­i­cal instil­la­tion com­ple­tion in the set­ting of non-mus­cle inva­sive blad­der can­cer treat­ment].Lailler, G ; Neuzil­let, Y ; Rouanne, M ; Lebret, TProg Urol20162679–8226653577
[Mol­e­c­u­lar, pre­clin­i­cal, and clin­i­cal com­par­a­tive data regard­ing dif­fer­ent strains of bacil­lus Cal­mette-Guérin (BCG): Review by the French Uro­log­i­cal Asso­ci­a­tion Oncol­o­gy Com­mit­tee (CCAFU)].Neuzil­let, Y ; Dubosq, F ; Xyli­nas, E ; Col­in, P ; Com­per­at, E ; Houede, N & alProg Urol201626121–826638801
The Com­ple­ment Sys­tem and Anti­body-Medi­at­ed Trans­plant Rejec­tion.Stites, E ; Le Quin­trec, M ; Thur­man, JMJ Immunol20151955525–3126637661
A pro­tein­uria cut-off lev­el of 0.7 g/day after 12 months of treat­ment best pre­dicts long-term renal out­come in lupus nephri­tis: data from the MAINTAIN Nephri­tis Tri­al.Tamirou, F ; Lauw­erys, BR ; Dall””Era, M ; Mack­ay, M ; Rovin, B ; Cervera, R & alLupus Sci Med20152e00012326629352
Deter­mi­na­tion of a Cen­tral Avas­cu­lar Tri­an­gle with­in the Obtu­ra­tor Fora­men: A Radioanatom­ic Study.Nyan­goh Tim­oh, K ; Bad­er, G ; Fau­con­nier, A ; Bar­rau, V ; Del­mas, V ; Touboul, CPLoS One201510e014364226624993
Nov­el ther­a­peu­tic tar­gets in advanced urothe­lial car­ci­no­ma.Rouanne, M ; Lori­ot, Y ; Lebret, T ; Soria, JCCrit Rev Oncol Hema­tol201698106–1526589398
[Not Avail­able].Seisen, T ; Com­pérat, E ; Col­in, P ; Pey­ron­net, B ; Ben­salah, K ; Rioux-Leclerc, N & alProg Urol201525805–626544374
[Not Avail­able].Neuzil­let, Y ; Rouanne, M ; Abdou, A ; Romen­s­ki, M ; Charti­er, V ; Lebret, TProg Urol201525794–526544351
[Not Avail­able].Salomon, L ; Bas­tu­ji-Garin, S ; Soulie, M ; Devonec, M ; Boutin, E ; Man­dron, E & alProg Urol20152579326544349
[Not Avail­able].Salomon, L ; Bas­tu­ji-Garin, S ; Maze­rolles, C ; Devonec, M ; Soulie, M ; Benoit, G & alProg Urol201525792–326544348
[Not Avail­able].Net, P ; Karny­cheff, F ; Butreau, M ; Lesprit, P ; Szeke­ly, B ; Vasse, M & alProg Urol201525776–726544320
[Not Avail­able].Rouanne, M ; Courbe­baisse, M ; Neuzil­let, Y ; Per­reaud, A ; Abdou, A ; Yon­neau, L & alProg Urol201525771–226544309
[Not Avail­able].Irani, J ; Gaunez, N ; Neuzil­let, Y ; Huygue, E ; Rouprêt, M ; Brif­faux, R & alProg Urol20152577126544308
[Not Avail­able].Neuzil­let, Y ; Jar­ry, L ; Rad­ules­cu, C ; Rouanne, M ; Lebret, TProg Urol201525770–126544306
[Not Avail­able].Mason-Lecomte, A ; Xyli­nas, E ; Col­in, P ; Com­per­at, E ; Dubosq, F ; Houedee, N & alProg Urol20152575826544282
[Not Avail­able].Durand-Zales­ki, I ; Rabe­tra­no, H ; Devonec, M ; Man­dron, E ; Soulie, M ; De la Taille, A & alProg Urol20152574226544250
[Not Avail­able].Neuzil­let, Y ; Ray­naud, J ; Pichon, A ; Ghoneim, T ; Lebret, T ; Rad­ules­cu, C & alProg Urol20152574126544247
[Not Avail­able].Lebret, T ; Rossi, D ; Zer­bib, M ; More­au, J ; Ruf­fion, A ; Neuzil­let, Y & alProg Urol20152573526544234
Long-Term Out­comes Among Par­tic­i­pants in the WEGENT Tri­al of Remis­sion-Main­te­nance Ther­a­py for Gran­u­lo­mato­sis With Polyangi­itis (Wegener”s) or Micro­scop­ic Polyangi­itis.Puéchal, X ; Pag­noux, C ; Per­rodeau, É ; Hami­dou, M ; Bof­fa, JJ ; Kyn­dt, X & alArthri­tis Rheuma­tol201668690–70126473755
Pre­op­er­a­tive low serum testos­terone is asso­ci­at­ed with high-grade prostate can­cer and an increased Glea­son score upgrad­ing.Pichon, A ; Neuzil­let, Y ; Bot­to, H ; Ray­naud, JP ; Rad­ules­cu, C ; Molin­ié, V & alProstate Can­cer Pro­sta­t­ic Dis201518382–726439747
Val­ue of positron emis­sion tomog­ra­phy in diag­nos­ing syn­chro­nous penile metas­ta­sis from urothe­lial blad­der can­cer.Rouanne, M ; Alham­ma­di, A ; Vilain, D ; Rad­ules­cu, C ; Lebret, TWorld J Surg Oncol20151327626376852
What do we know about treat­ment sequenc­ing of abi­raterone, enza­lu­tamide, and chemother­a­py in metasta­t­ic cas­tra­tion-resis­tant prostate can­cer?Leb­dai, S ; Bas­set, V ; Branchere­au, J ; de La Taille, A ; Fla­mand, V ; Lebret, T & alWorld J Urol201634617–2426373956
Long term out­comes of trans­plan­ta­tion using kid­neys from expand­ed cri­te­ria donors: prospec­tive, pop­u­la­tion based cohort study.Aubert, O ; Kamar, N ; Vernerey, D ; Vigli­et­ti, D ; Mar­tinez, F ; Duong-Van-Huyen, JP & alBMJ2015351h355726232393
Report­ed Out­come After Valve-Spar­ing Aor­tic Root Replace­ment for Aor­tic Root Aneurysm: A Sys­tem­at­ic Review and Meta-Analy­sis.Arabkhani, B ; Mookhoek, A ; Di Cen­ta, I ; Lansac, E ; Bekkers, JA ; De Lind Van Wijn­gaar­den, R & alAnn Tho­rac Surg20151001126–3126228603
Embryo Form Project: An orig­i­nal tech­nique for the three-dimen­sion­al recon­struc­tion of human embryo mor­phol­o­gy.Labrousse, M ; Micard, E ; Ton­nelet, R ; Cen­dre, R ; Del­mas, V ; Naidich, T & alReprod Tox­i­col2015581–726219247
Per­ineal or Abdom­i­nal Approach First Dur­ing Inter­sphinc­teric Resec­tion for Low Rec­tal Can­cer: Which Is the Best Strat­e­gy?Kan­so, F ; Mag­giori, L ; Debove, C ; Chau, A ; Fer­ron, M ; Panis, YDis Colon Rec­tum201558637–4426200677
Effi­ca­cy of trip­tore­lin pamoate 11.25 mg admin­is­tered sub­cu­ta­neous­ly for achiev­ing med­ical cas­tra­tion lev­els of testos­terone in patients with local­ly advanced or metasta­t­ic prostate can­cer.Lebret, T ; Rouanne, M ; Hublarov, O ; Jin­ga, V ; Petko­va, L ; Kot­sev, R & alTher Adv Urol20157125–3426161143
Anatom­i­cal insights into sacro­colpopexy for mul­ti­com­part­ment pelvic organ pro­lapse.Ercoli, A ; Cam­pagna, G ; Del­mas, V ; Fer­rari, S ; Mor­ciano, A ; Scam­bia, G & alNeu­rourol Uro­dyn201635813–826147420
[Fol­low-up of urothe­lial car­ci­no­ma: Review of the Can­cer Com­mit­tee of the French Asso­ci­a­tion of Urol­o­gy].Col­in, P ; Neuzil­let, Y ; Pig­not, G ; Rouprêt, M ; Com­per­at, E ; Lar­ré, S & alProg Urol201525616–2426141291
Obe­si­ty and hypog­o­nadism are asso­ci­at­ed with an increased risk of pre­dom­i­nant Glea­son 4 pat­tern on rad­i­cal prosta­te­c­to­my spec­i­men.Neuzil­let, Y ; Ray­naud, JP ; Lebret, T ; Pichon, A ; Rad­ules­cu, C ; Molin­ie, V & alHorm Mol Biol Clin Inves­tig201522101–926047422
Eval­u­a­tion of the effect of a laparo­scop­ic robo­t­ized nee­dle hold­er on ergonom­ics and skills.Ben­sign­or, T ; Morel, G ; Rever­sat, D ; Fuks, D ; Gayet, BSurg Endosc201630446–45426017905
A 16-gene assay to pre­dict recur­rence after surgery in localised renal cell car­ci­no­ma: devel­op­ment and val­i­da­tion stud­ies.Rini, B ; God­dard, A ; Kneze­vic, D ; Mad­dala, T ; Zhou, M ; Aydin, H & alLancet Oncol201516676–8525979595
Par­tial nephrec­to­my for renal tumors in soli­tary kid­neys: post­op­er­a­tive renal func­tion dynam­ics.Ghoneim, TP ; Sjoberg, DD ; Lowrance, W ; Shari­at, SF ; Sav­age, C ; Bern­stein, M & alWorld J Urol2015332023–925966661
Man­age­ment of Node Only Recur­rence after Pri­ma­ry Local Treat­ment for Prostate Can­cer: A Sys­tem­at­ic Review of the Lit­er­a­ture.Plous­sard, G ; Almeras, C ; Brig­an­ti, A ; Gian­nar­i­ni, G ; Hen­nequin, C ; Ost, P & alJ Urol2015194983–825963190
Pos­i­tive sur­gi­cal mar­gins after rad­i­cal prosta­te­c­to­my: What should we care about?Pet­te­nati, C ; Neuzil­let, Y ; Rad­ules­cu, C ; Hervé, JM ; Molin­ié, V ; Lebret, TWorld J Urol2015331973–825939539
A new tech­nique for intra-abdom­i­nal arter­ies revas­cu­lar­iza­tion via extra-anatom­ic bypass from the bra­chio­cephal­ic artery with a video­scop­ic ret­roster­nal tun­nel.Javer­li­at, I ; Pichon, A ; Glo­ri­on, M ; Coscas, R ; Goëau-Bris­son­nière, O ; Cog­gia, MJ Vasc Surg201562256–825936654
Char­ac­ter­is­tics of unde­tect­ed prostate can­cer on dif­fu­sion-weight­ed MR Imag­ing at 3‑Tesla with a b‑value of 2000s/mm(2): Imag­ing-patho­log­ic cor­re­la­tion.Bar­ral, M ; Cor­nud, F ; Neuzil­let, Y ; Lon­champt, E ; Las­salle, L ; Delon­champ, NB & alDiagn Interv Imag­ing201596923–925934182
Anti-fac­tor H autoan­ti­bod­ies in C3 glomeru­lopathies and in atyp­i­cal hemolyt­ic ure­mic syn­drome: one tar­get, two dis­eases.Blanc, C ; Tog­a­r­si­malemath, SK ; Chau­vet, S ; Le Quin­trec, M ; Moulin, B ; Buch­ler, M & alJ Immunol20151945129–3825917093
A mul­ti­fac­eted inter­ven­tion designed to improve med­ical man­age­ment of mod­er­ate to advanced chron­ic kid­ney dis­ease in HIV-infect­ed patients: a clus­ter ran­dom­ized tri­al.Abgrall, S ; Rachas, A ; Tour­ret, J ; Isnard-Bag­nis, C ; Bil­laud, E ; Tat­tevin, P & alClin Infect Dis201561375–8425904366
Com­bined ART start­ed dur­ing acute HIV infec­tion pro­tects cen­tral mem­o­ry CD4+ T cells and can induce remis­sion.Chéret, A ; Bac­chus-Souf­fan, C ; Avet­tand-Fenoël, V ; Mélard, A ; Nem­bot, G ; Blanc, C & alJ Antimi­crob Chemoth­er2015702108–2025900157
HIV‑1 sub­type B‑infected MSM may have dri­ven the spread of trans­mit­ted resis­tant strains in France in 2007-12: impact on sus­cep­ti­bil­i­ty to first-line strate­gies.Frange, P ; Assoumou, L ; Descamps, D ; Chéret, A ; Gou­jard, C ; Tran, L & alJ Antimi­crob Chemoth­er2015702084–925885327
[Intrin­sic sphinc­ter defi­cien­cy and female uri­nary incon­ti­nence].Cour, F ; Le Nor­mand, L ; Lapray, JF ; Her­mieu, JF ; Peyrat, L ; Yiou, R & alProg Urol201525437–5425864653
Long-term fol­low-up of the MAINTAIN Nephri­tis Tri­al, com­par­ing aza­thio­prine and mycophe­no­late mofetil as main­te­nance ther­a­py of lupus nephri­tis.Tamirou, F ; D””Cruz, D ; San­gle, S ; Remy, P ; Vas­con­ce­los, C ; Fiehn, C & alAnn Rheum Dis201675526–3125757867
Sur­gi­cal anato­my of the aor­tic annu­lus: land­marks for exter­nal annu­lo­plas­ty in aor­tic valve repair.Khelil, N ; Sleilaty, G ; Pal­ladi­no, M ; Fou­da, M ; Escan­de, R ; Debauchez, M & alAnn Tho­rac Surg2015991220–625728963
Inten­sive five-drug anti­retro­vi­ral ther­a­py reg­i­men ver­sus stan­dard triple-drug ther­a­py dur­ing pri­ma­ry HIV‑1 infec­tion (OPTIPRIM-ANRS 147): a ran­domised, open-label, phase 3 tri­al.Chéret, A ; Nem­bot, G ; Mélard, A ; Las­coux, C ; Sla­ma, L ; Miail­h­es, P & alLancet Infect Dis201515387–9625701561
Clin­i­co­patho­log­i­cal char­ac­ter­is­tics of urothe­lial blad­der can­cer in patients less than 40 years old.Com­pérat, E ; Lar­ré, S ; Roupret, M ; Neuzil­let, Y ; Pig­not, G ; Quin­tens, H & alVir­chows Arch2015466589–9425697540
Prog­nos­tic score for recur­rence after Whipple”s pan­cre­ati­co­duo­denec­to­my for ampullary car­ci­no­mas; results of an AGEO ret­ro­spec­tive mul­ti­cen­ter cohort.Colus­si, O ; Voron, T ; Pozet, A ; Ham­mel, P ; Sauvanet, A ; Bachet, JB & alEur J Surg Oncol201541520–625680954
VEGF‑A mod­u­lates expres­sion of inhibito­ry check­points on CD8+ T cells in tumors.Voron, T ; Colus­si, O ; Mar­che­teau, E ; Per­not, S ; Nizard, M ; Pointet, AL & alJ Exp Med2015212139–4825601652
Eculizum­ab for treat­ment of rapid­ly pro­gres­sive C3 glomeru­lopa­thy.Le Quin­trec, M ; Lionet, A ; Kan­del, C ; Bour­don, F ; Gnem­mi, V ; Colom­bat, M & alAm J Kid­ney Dis201565484–925530108
Patho­log­i­cal response of local­ly advanced rec­tal can­cer to pre­op­er­a­tive chemother­a­py with­out pelvic irra­di­a­tion.Ben­sign­or, T ; Brou­quet, A ; Dar­i­ane, C ; Thi­rot-Bidault, A ; Lazure, T ; Julié, C & alCol­orec­tal Dis201517491–825524450
Per­sis­tent uri­nary reten­tion after surgery for deep infil­trat­ing endometrio­sis: a mul­ti-cen­ter series of 16 cas­es.Aza­ïs, H ; Rubod, C ; Ghoneim, T ; Vas­sili­eff, M ; Bail­ly, E ; Boileau, L & alArch Gynecol Obstet20152911333–925516176
Trends in renal func­tion after rad­i­cal cys­tec­to­my and ileal con­duit diver­sion: new insights regard­ing esti­mat­ed glomeru­lar fil­tra­tion rate vari­a­tions.Rouanne, M ; Per­reaud, A ; Letang, N ; Yon­neau, L ; Neuzil­let, Y ; Hervé, JM & alClin Gen­i­tourin Can­cer201513e139-4425514859
Parotid gland metas­ta­sis from prostate can­cer: is doc­etax­el still the best treat­ment option?Hélis­sey, C ; Rouanne, M ; Arnaud, FX ; Le Moulec, SAnti­cancer Drugs201526367–7025486600
Risk fac­tors for cir­cum­fer­en­tial R1 resec­tion after neoad­ju­vant radiochemother­a­py and laparo­scop­ic total mesorec­tal exci­sion: a study in 233 con­sec­u­tive patients with mid or low rec­tal can­cer.Debove, C ; Mag­giori, L ; Chau, A ; Kan­so, F ; Fer­ron, M ; Panis, YInt J Col­orec­tal Dis201530197–20325466419
What hap­pens after R1 resec­tion in patients under­go­ing laparo­scop­ic total mesorec­tal exci­sion for rec­tal can­cer? A study in 333 con­sec­u­tive patients.Debove, C ; Mag­giori, L ; Chau, A ; Kan­so, F ; Fer­ron, M ; Panis, YCol­orec­tal Dis201517197–20425421215
Long-term fol­low-up of TaG1 non-mus­cle-inva­sive blad­der can­cer.Olivi­er Bos­set, P ; Neuzil­let, Y ; Pao­let­ti, X ; Molin­ie, V ; Bot­to, H ; Lebret, TUrol Oncol20153320.e1-20.e725282704
Immuno­he­ma­to­log­ic tol­er­ance of chron­ic trans­fu­sion exchanges with ery­thro­cy­ta­phere­sis in sick­le cell dis­ease.Michot, JM ; Driss, F ; Gui­t­ton, C ; Moh Klaren, J ; Lefeb­vre, F ; Chamil­lard, X & alTrans­fu­sion201555357–6325251746
Stan­dard­ized approach to valve repair using an expan­si­ble aor­tic ring ver­sus mechan­i­cal Ben­tall: ear­ly out­comes of the CAVIAAR mul­ti­cen­tric prospec­tive cohort study.Lansac, E ; Bou­chot, O ; Arnaud Crozat, E ; Haci­ni, R ; Doguet, F ; Demaria, R & alJ Tho­rac Car­dio­vasc Surg2015149S37-4525240525
Three-dimen­sion­al recon­struc­tion of the low­er limb”s venous sys­tem in human fetus­es using the com­put­er-assist­ed anatom­i­cal dis­sec­tion (CAAD) tech­nique.Kurobe, N ; Hakkakian, L ; Chahim, M ; Del­mas, V ; Veke­mans, M ; Uhl, JFSurg Radi­ol Anat201537231–825047542
Pre­dict­ing the risk of har­bor­ing high-grade dis­ease for patients diag­nosed with prostate can­cer scored as Glea­son ≤ 6 on biop­sy cores.Seisen, T ; Roudot-Tho­raval, F ; Bos­set, PO ; Beaugerie, A ; Allo­ry, Y ; Vor­dos, D & alWorld J Urol201533787–9224985552
Prostate can­cer inci­dence on cysto­prosta­te­c­to­my spec­i­mens is direct­ly linked to age: results from a mul­ti­cen­tre study.Pig­not, G ; Salomon, L ; Leba­cle, C ; Neuzil­let, Y ; Lunar­di, P ; Rischmann, P & alBJU Int201511587–9324825727
An expan­si­ble aor­tic ring to pre­serve aor­tic root dynam­ics after aor­tic valve repair.Wuliya, M ; Sleilaty, G ; Di Cen­ta, I ; Khelil, N ; Berre­bi, A ; Czitrom, D & alEur J Car­dio­tho­rac Surg201547482–90; dis­cus­sion 49024755102
Retour haut de page